Quarterly Consolidated Statement Of Cash Flows

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7724524

Concept 2017-04-01 to
2018-03-31
As at
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,830,863,000 JPY
933,750,000 JPY
Interest and dividends received
8,879,000 JPY
9,746,000 JPY
Interest paid
-346,724,000 JPY
-408,826,000 JPY
Income taxes paid
-148,763,000 JPY
-1,384,478,000 JPY
Net cash provided by (used in) operating activities
1,344,254,000 JPY
-849,807,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,012,881,000 JPY
-789,658,000 JPY
Proceeds from sale of property, plant and equipment
2,152,000 JPY
106,847,000 JPY
Purchase of investment securities
JPY
-27,000 JPY
Proceeds from sale of investment securities
183,000 JPY
508,994,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-26,786,000 JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
JPY
122,459,000 JPY
Loan advances
JPY
-49,006,000 JPY
Proceeds from collection of loans receivable
48,285,000 JPY
17,394,000 JPY
Other, net
-10,542,000 JPY
26,984,000 JPY
Net cash provided by (used in) investing activities
837,824,000 JPY
-314,206,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
850,000,000 JPY
5,821,200,000 JPY
Repayments of long-term borrowings
-5,842,661,000 JPY
-6,657,678,000 JPY
Redemption of bonds
-50,000,000 JPY
JPY
Other, net
-116,000 JPY
JPY
Net cash provided by (used in) financing activities
-4,224,327,000 JPY
3,815,122,000 JPY
Effect of exchange rate change on cash and cash equivalents
-87,461,000 JPY
-152,941,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,129,710,000 JPY
2,498,166,000 JPY
Cash and cash equivalents
5,294,076,000 JPY
7,423,786,000 JPY
4,925,620,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.